Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001004995-03-000001
Filing Date
2003-11-25
Accepted
2003-11-25 15:32:56
Documents
1
Period of Report
2003-11-24

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3061
  Complete submission text file 0001004995-03-000001.txt   4953
Mailing Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BLVD. SUITE 200 SO. SAN FRANCISCO CA 94080 6506262200
CELLEGY PHARMACEUTICALS INC (Issuer) CIK: 0000887247 (see all company filings)

EIN.: 820429727 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2350 AIRPORT FREEWAY STE 222 BEDFORD TX 76022
Business Address 2350 AIRPORT FREEWAY SUITE 280 BEDFORD TX 76022
ADAMS JOHN Q (Reporting) CIK: 0001004995 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26372 | Film No.: 031023162